01 / What you get
Compliance infrastructure built to hold
USP 795, 797, and 800 compliant across sterile and non-sterile operations. Engineered into facility design, not bolted on to pass the next audit.
ABOUT META
Twelve years in.Still building.
New compounding pharmacies emerge every cycle to chase whatever drug is in shortage. Meta has been operating since 2014 — chosen by practices that need a pharmacy still here in five years.
§01 · ORIGIN
Built before the boom. Still here after the crackdown.
Meta Pharmacy was founded in 2014 in Las Vegas — before the GLP-1 explosion, before the wave of compounding startups, and before the regulatory environment that now governs the industry had fully taken shape.
The years since have not been quiet. The Drug Quality and Security Act reshaped what it meant to operate as a 503A pharmacy. FDA oversight intensified. COVID disrupted supply chains. Semaglutide created a demand surge that attracted hundreds of new compounders overnight — many of whom couldn't survive the enforcement actions that followed.
Meta was here before the market got crowded. We'll be here after it clears.
Through every one of those shifts, Meta kept operating — because the compliance infrastructure, quality systems, and operational discipline were built to hold. That foundation is why we're expanding now, instead of catching up.
Today, Meta is investing in what the next decade of compounding will require: expanded operational leadership, deeper compliance infrastructure, and a second Las Vegas facility opening Q3 2026 — purpose-built to run at standard from day one.
§02 · INDUSTRY CONTEXT
Twelve years through every cycle.
The compounding landscape has changed significantly since 2014 — DQSA, COVID, the GLP-1 surge, the enforcement wave that followed. Meta has been operating through all of it.
- 2014Founded
Meta opens in Las Vegas
Operations begin as a 503A compounding pharmacy. The Drug Quality and Security Act had just passed the year prior, establishing the federal framework that governs compounding to this day. Compliance was built in from the start.
- 2016–19Regulatory tightening
FDA enforcement ramps up across the industry
FDA issued increasing warning letters and facility inspections under the new 503A framework. Pharmacies that hadn’t built proper quality systems faced significant disruption. Meta’s compliance foundation held.
- 2020COVID disruption
Supply chains tested across the board
Pharmaceutical supply chains saw raw-material shortages and demand volatility. Operational resilience separated pharmacies that kept serving providers from those that couldn’t. Meta kept dispensing throughout.
- 2022–24GLP-1 boom
Semaglutide shortage drives compounding demand
FDA-declared drug shortages opened the door for 503A pharmacies to compound semaglutide and tirzepatide. Hundreds of new pharmacies entered the market to capture demand — many with minimal compliance infrastructure.
- 2025Enforcement wave
FDA actions on GLP-1 compounders intensify
Pharmacies that had built their entire operation around GLP-1 compounding without proper compliance infrastructure faced shutdowns and cease-and-desist actions. Practices serving those pharmacies absorbed the disruption.
- Q3 2026Expansion
Second 12,000 sq ft facility opens
After a decade of consistent operations, Meta expands to two Las Vegas facilities. Same compliance standards that have defined the operation since day one — applied to the volume and form-factor mix the next decade will require.
§03 · FACILITY
12,000 sq ft of new infrastructure.
A second Las Vegas facility, built to USP standard from facility design forward — sterile, non-sterile, and hazardous handling. Current site stays operational throughout commissioning.
- Footprint
- 12,000sq ft
- Purpose-built
- Location
- Las VegasNV
- Second site — joins current operating facility
- Sterile suite
- USP 797compliant
- Anteroom + ISO 7 buffer, classified at design
- Non-sterile
- USP 795compliant
- Dedicated compounding rooms, separated from sterile
- Hazardous handling
- USP 800compliant
- Segregated negative-pressure suite
- Opening
- Q3 2026
- Operational targets locked at construction sign-off
- Continuity
- Zerodowntime
- Current facility stays live through commissioning
§04 · WHY IT MATTERS
Your patients don't care about pharmacy churn. You do.
When a pharmacy shuts down, changes its formulary without notice, or can't fill an order because compliance cracked under scrutiny — that disruption lands on your practice. You're the one making the call.
- 02 / What you get
Formulary you can plan around
A decade of operations means a formulary built on what actually works — not a list assembled to attract sign-ups. Changes are communicated, not discovered on the next refill.
- 03 / What you get
A full formulary, not just GLP-1.
Plenty of compounders only fill GLP-1s, leaving every other script to scatter across pharmacies. Meta runs a full formulary — sterile and non-sterile, controlled substances, and hormones — so one partner covers the whole patient.
- 04 / What you get
A team that has seen what you’ve seen
Operational leadership at Meta came up through larger pharmacy groups. They know what it takes to run a pharmacy practices can actually depend on — and built this one to that bar.
§05 · Partner with Meta
Open a partneraccount.
Tell us who you are, what you fulfill today, and where you're trying to take it. We verify credentials and route you to the right person — no generic intake queue. One business day to reply.
Submitting this form does not create a provider relationship. We verify credentials against state boards and follow up within one business day. We do not dispense to patients without a prescribing provider relationship.